These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29547977)

  • 1. Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review.
    Foolad F; Taylor BD; Shelburne SA; Arias CA; Aitken SL
    J Antimicrob Chemother; 2018 Sep; 73(9):2277-2283. PubMed ID: 29547977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA; McCoy D; Desai S; Nyirenda T; Bicking K
    J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.
    Munita JM; Murray BE; Arias CA
    Int J Antimicrob Agents; 2014 Nov; 44(5):387-95. PubMed ID: 25261158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of vancomycin-resistant enterococcal infections].
    Lund LC; Holzknecht BJ; Justesen US
    Ugeskr Laeger; 2018 Apr; 180(16):. PubMed ID: 29690991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    Patel R; Gallagher JC
    Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
    Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
    J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD; Hsu AJ
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a daptomycin dose-optimization protocol.
    Tran TT; Palmer HR; Weston J; Hirsch EB; Shah DN; Cottreau J; Tam VH; Garey KW
    Am J Health Syst Pharm; 2012 Jun; 69(11):979-84. PubMed ID: 22610031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
    Chuang YC; Wang JT; Lin HY; Chang SC
    BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
    Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
    Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
    Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Patel K
    Int J Antimicrob Agents; 2016 Sep; 48(3):231-8. PubMed ID: 27475877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.
    Avery LM; Kuti JL; Weisser M; Egli A; Rybak MJ; Zasowski EJ; Arias CA; Contreras GA; Chong PP; Aitken SL; DiPippo AJ; Wang JT; Britt NS; Nicolau DP
    Int J Antimicrob Agents; 2019 Sep; 54(3):346-350. PubMed ID: 31284042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.